INS and obesity disorder: Increased ROS levels in obesity are associated with adipogenic BMSCs that demonstrate a shift from glycolysis towards higher oxidative phosphorylation, enhanced insulin signaling, glucose transport, lipid metabolism, and senescence (Guntur et al., 2018; Tencerova et al., 2019b).